Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft substitutes and the uniqueness of i‑FACTOR Peptide Enhanced Bone Graft, a small peptide technology in an interview with Kim French, Sr. Analyst, SmartTRAK Orthbio.

A transcript of SmartTRAK's interview with Glen Kashuba and Jeff Marx is below, or click on the following video to listen to the interview.

SmartTRAK is excited to be attending AOFAS 2018 - American Orthopaedic Foot & Ankle Society - on July 11-14, 2018 in Boston, Massachusetts.

Representing SmartTRAK will be Natasha Weeks, Sr. Analyst, Trauma & Extremities Fixation, Christopher McCarthy, VP Corporate Accounts, Orthopedics and Neuro and Michelle Calderon, Account Manager, Orthopedics. Please contact us if you would like a meeting!

SmartTRAK looks behind the curtain at the interplay of factors truly driving growth in the US Soft Tissue Fixation Market.

With the US Soft Tissue Fixation Market worth an estimated $1.5B, SmartTRAK looked behind industry’s curtain at the interplay of factors driving the 5.3% CAGR in the sports medicine market to see what’s truly driving growth in the market. Does clinical research drive product development? Or does industry develop and market products that drive usage followed by studies that measure their efficacy? From aggressive marketing campaigns to company compensation plans to sole source agreements, there is an increasing number of factors driving the soft tissue fixation market outside of research and clinical findings.

SmartTRAK's  Trauma & Extremities Fixations Sr. Analyst Natasha Weeks identified several key product trends at the Orthopaedic Trauma Association’s (OTA) 33rd Annual Meeting in Vancouver, BC Oct. 11-14, 2017, as manufacturers looked to differentiate themselves and gain share in the US Trauma market, projected to reach over $2.2B by 2021. 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Soft Tissue Fixation Market Recap.

Seasonality slowed Soft Tissue Fixation market growth, but the addition of biologics to RC repair implants makes the future promising. The US soft tissue fixation market continued to grow at 3.3% YoY...

Among the many topics covered in the full Q118 Soft Tissue Fixation Market Recap are: 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 OrthoBio Market Recap.

Up 3.4% YoY, the OrthoBio market is off to a good start. Companies that are surpassing growth expectations tend to have differentiated products, focused efforts and incremental pull through from synergistic sales strategies. Market subtleties like reimbursement, pricing pressures and market loss due to newer competition continue to afflict some companies and segments...

Among the many topics covered in the full Q118 OrthoBio Market Recap are: 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Spine Market Recap.

While we saw a slight upturn in the market in Q4, the beginning of 2018 has again revealed the Spine market’s true colors – with a slight decline in the overall market and notable pricing pressures. With -1.9% YoY growth, Stryker’s US Spine revenues were challenged by market softness as well as low-double digit (~10%) price declines across core product lines. K2M management reported ...

Among the many topics covered in the Q118 Spine Market Recap are:

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Extremities Market Recap.

The US Extremities Market experienced a slight dip in Q118, with sequential growth down from +8.4% to +6.9% that extended into all categories. While Q118 was relatively quiet, FDA clearances, new competitive products and new players in Shoulder, Ankles and Fixation should heat up the segment in 2018.

Among the many topics covered in the Q118 Extremities Market Recap are:

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Total Joints Market Recap.